- Home
- DYAI vs ADGM Comparison
DYAI vs ADGM Comparison
Compare DYAI & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- ADGM
- Stock Information
- Founded
- DYAI 1979
- ADGM 2011
- Country
- DYAI United States
- ADGM United States
- Employees
- DYAI N/A
- ADGM N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- ADGM
- Sector
- DYAI Health Care
- ADGM
- Exchange
- DYAI Nasdaq
- ADGM NYSE
- Market Cap
- DYAI 31.5M
- ADGM 33.4M
- IPO Year
- DYAI 2004
- ADGM N/A
- Fundamental
- Price
- DYAI $1.47
- ADGM $1.70
- Analyst Decision
- DYAI Strong Buy
- ADGM
- Analyst Count
- DYAI 1
- ADGM 0
- Target Price
- DYAI $6.00
- ADGM N/A
- AVG Volume (30 Days)
- DYAI 91.0K
- ADGM 52.4K
- Earning Date
- DYAI 11-12-2024
- ADGM 11-14-2024
- Dividend Yield
- DYAI N/A
- ADGM N/A
- EPS Growth
- DYAI N/A
- ADGM N/A
- EPS
- DYAI N/A
- ADGM N/A
- Revenue
- DYAI $3,364,548.00
- ADGM $543,000.00
- Revenue This Year
- DYAI $51.30
- ADGM N/A
- Revenue Next Year
- DYAI $73.26
- ADGM N/A
- P/E Ratio
- DYAI N/A
- ADGM N/A
- Revenue Growth
- DYAI 13.82
- ADGM 187.30
- 52 Week Low
- DYAI $0.93
- ADGM $1.69
- 52 Week High
- DYAI $2.67
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- DYAI 44.84
- ADGM N/A
- Support Level
- DYAI $1.47
- ADGM N/A
- Resistance Level
- DYAI $1.70
- ADGM N/A
- Average True Range (ATR)
- DYAI 0.16
- ADGM 0.00
- MACD
- DYAI -0.05
- ADGM 0.00
- Stochastic Oscillator
- DYAI 3.70
- ADGM 0.00
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.